Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Fda crawled date : 2021 - 12 - 09 save search
Aprea Therapeutics Announces Removal of FDA Clinical Hold on Eprenetapopt in Lymphoid Malignancies
Published: 2021-12-09 (Crawled : 20:00) - biospace.com/
APRE | $5.1201 6.3% 2.6K
|
Health Technology
|
| O: 13.62%
H: 0.4%
C: -10.07%
clinical hold fda therapeutics
VUITY™ (pilocarpine HCI ophthalmic solution) 1.25%, the First and Only FDA-Approved Eye Drop to Treat Age-Related Blurry Near Vision (Presbyopia), is Now Available
Published: 2021-12-09 (Crawled : 20:00) - biospace.com/
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.28%
H: 1.84%
C: 1.59%
fda eye drop presbyopia
CytoDyn Submits Protocol with the FDA for Phase 3 Registrational Trial of Leronlimab for Critically Ill COVID-19 Population
Published: 2021-12-09 (Crawled : 19:00) - biospace.com/
CYDY | $0.1501 0.06% 790K
|
Manufacturing
|
| O: 3.81%
H: 3.67%
C: -5.5%
covid-19 fda trial covid phase 3
Hemp, Inc. Reports: Bipartisan Bill Demands FDA to Regulate Hemp-Derived CBD Food
Published: 2021-12-09 (Crawled : 19:00) - globenewswire.com
PPRUF | News | $364.27 37.56% 850
|
Consumer Non-Durables
|
| O: 2.43%
H: 0.0%
C: -0.68%
PPRUY | News | $36.96 -0.11% 220K
|
Manufacturing
|
| O: 0.33%
H: 0.0%
C: -0.55%
fda ema cbd food
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older
Published: 2021-12-09 (Crawled : 18:00) - globenewswire.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: 0.69%
H: 0.68%
C: 0.68%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: -3.53%
H: 0.32%
C: -4.65%
covid-19 fda covid authorization vaccine merge order emergency use authorization
Heron Therapeutics Announces FDA Approval of a Significant Indication Expansion for ZYNRELEF®
Published: 2021-12-09 (Crawled : 14:30) - biospace.com/
HRTX M | $2.805 8.3% 7.66% 6.6M
|
Health Technology
|
| O: 0.72%
H: 18.55%
C: 10.58%
zynrelef fda expansion fda approval approval therapeutics
FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20 Insertion Mutant Non-Small Cell Lung Cancer Tumor Tissue
Published: 2021-12-09 (Crawled : 14:00) - biospace.com/
TMO | News | $574.59 4.78% -1.12% 2.5M
|
Health Technology
|
| O: 1.29%
H: 0.0%
C: 0.0%
diagnostic fda lung cancer cancer
Cytokinetics Announces Receipt of Breakthrough Therapy Designation from FDA for Aficamten
Published: 2021-12-09 (Crawled : 13:00) - globenewswire.com
CYTK | $65.56 -1.1% -1.11% 1.3M
|
Health Technology
|
| O: -2.93%
H: 0.0%
C: 0.0%
fda therapy breakthrough therapy designation
Cytokinetics Announces Receipt of Breakthrough Therapy Designation from FDA for AficamtenFDA Granted Designation for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy Based on Results of REDWOOD-HCM
Published: 2021-12-09 (Crawled : 13:00) - biospace.com/
CYTK | $65.56 -1.1% -1.11% 1.3M
|
Health Technology
|
| O: -2.93%
H: 0.0%
C: 0.0%
treatment fda cardio granted therapy results breakthrough therapy designation
MindMed Engages in Productive Pre-Submission Meeting with FDA for Development of the MindMed Session Monitoring System
Published: 2021-12-09 (Crawled : 12:30) - prnewswire.com
MNMD | $8.885 2.36% 2.31% 1.2M
|
n/a
|
| O: 6.95%
H: 1.5%
C: -5.0%
fda submission resubmission
Ocugen, Inc. Announces U.S. FDA Acceptance of Investigational New Drug Application to Initiate a Phase 1/2 Clinical Trial for Gene Therapy Candidate OCU400 to Treat Inherited Retinal Degeneration
Published: 2021-12-09 (Crawled : 12:30) - globenewswire.com
OCGN | News A | $1.24 0.0% 6.9M
|
Health Technology
|
| O: 7.46%
H: 0.31%
C: -12.81%
ocu400 new drug fda application gene therapy drug trial fda acceptance phase 1 therapy retina
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.